Zepp Health (NYSE:ZEPP) PT Set at $13.87 by Fundamental Research

Fundamental Research set a $13.87 price objective on Zepp Health (NYSE:ZEPP) in a report released on Tuesday morning,BayStreet.CA reports. The brokerage currently has a buy rating on the stock.

Zepp Health Stock Performance

Shares of Zepp Health stock opened at $2.54 on Tuesday. The stock has a market capitalization of $38.16 million, a price-to-earnings ratio of -1.01 and a beta of 0.71. The firm’s fifty day simple moving average is $2.88 and its 200-day simple moving average is $3.02. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.21 and a quick ratio of 0.87. Zepp Health has a 12 month low of $2.06 and a 12 month high of $4.38.

Institutional Investors Weigh In On Zepp Health

A hedge fund recently bought a new stake in Zepp Health stock. Mandatum Life Insurance Co Ltd acquired a new position in shares of Zepp Health Co. (NYSE:ZEPP) in the fourth quarter, according to its most recent disclosure with the SEC. The firm acquired 10,750 shares of the company’s stock, valued at approximately $28,000. Mandatum Life Insurance Co Ltd owned 0.07% of Zepp Health at the end of the most recent quarter. Institutional investors own 52.61% of the company’s stock.

Zepp Health Company Profile

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.